XML 17 R9.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

During the three months ended June 30, 2024, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement (as such terms are defined pursuant to Item 408(a) of Regulation S-K), except as follows:

On June 21, 2024, David Campbell, Ph.D., our President and Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 120,000 shares of the Company's common stock until September 27, 2025.
 

On June 28, 2024, Tommy DiRaimondo, Ph.D., our Chief Scientific Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 96,100 shares of the Company's common stock until June 27, 2025.
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
David Campbell  
Trading Arrangements, by Individual  
Name David Campbell
Title President and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 21, 2024
Aggregate Available 120,000
Tommy DiRaimondo  
Trading Arrangements, by Individual  
Name Tommy DiRaimondo
Title Chief Scientific Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 28, 2024
Aggregate Available 96,100